# Apersys

> Apersys develops advanced organ perfusion technology to extend organ viability, enable real-time assessment, and improve transplantation outcomes.

Apersys AG is a Swiss medical technology company spun off from ETH Zürich, the University of Zurich, the University Hospital Zurich (USZ), and Wyss Zurich. The platform supports multi-day ex-vivo liver perfusion, automated control, and therapeutic intervention before transplantation.

## Pages

- [Home](/): Overview of the Apersys organ perfusion platform.
- [Technology](/technology): How the multi-day perfusion platform works.
- [Applications](/applications): Clinical and research applications of the platform.
- [Partners](/partners): Institutional and clinical partners.
- [News & Evidence](/news): Publications, conferences, and announcements.
- [About](/about): Company background, mission, and leadership.
- [Careers](/careers): Open positions at Apersys.
- [Contact](/contact): Request information or partnership inquiries.